Cover Image

Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007.

Bibliographic Details
Corporate Authors:	United States. Congress. House. Committee on Oversight and Government Reform, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	Washington : U.S. G.P.O. : 2007.
Series:	U.S. Congressional Hearings.
Subjects:	Prescription pricing > Corrupt practices > United States. Drugs > Prices > United States. Waste in government spending > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007.
Published: (2007)

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)

Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)

Brand-name prescription drug pricing : lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters.
Published: (2009)

The big fix : how the pharmaceutical industry rips off American consumers /
by: Greider, Katharine
Published: (2003)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Less than half of Part D sponsors voluntarily reported data on potential fraud and abuse.
Published: (2014)

Prescription for good health : keeping pharmaceutical prices under control : a briefing /
Published: (1992)

Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)

Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996.
Published: (1996)

Medicare hospital pharmaceuticals : survey shows price variation and highlights data collection lessons and outpatient rate-setting challenges for CMS : report to congressional committees.
Published: (2006)

Republican Prescription Drug Legislation (H.R. 4954) Will Not End Drug Price Discrimination /
Published: (2002)

Response to Drug Industry Claims on Prescription Drug Price Differences Between the U.S. and Other Countries /
Published: (2002)

Enactment of Republican Drug Import Legislation in 2000 Failed To Reduce Drug Prices for Uninsured Seniors /
Published: (2002)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)

Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study.
Published: (2010)

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /
by: Jaggar, Sarah F.
Published: (1996)

New Medicare Drug Plans Fail To Provide Meaningful Drug Price Discounts.
Published: (2005)

Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers [as printed] : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, September 5, 2001.
Published: (2003)

Prescription Drug Prices in Canada, Europe, and Japan /
Published: (2001)

Sudden price spikes in decades-old prescription drugs : inside the monopoly business model : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, March 17, 2016.
Published: (2022)

Budgeting To Fight Waste, Fraud and Abuse.
Published: (2007)

Formulating and implementing pharmaceutical pricing policies : challenges, case studies and lessons learned from medicine price control /
Published: (2025)

Defective pricing of defense contracts : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, September 23, 1987.
Published: (1988)

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.
Published: (2004)

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.
Published: (2004)

Description of subtitle J - drug pricing : budget reconciliation legislative recommendations : scheduled for markup by the House Committee on Ways and Means on September 14, 2021 /
Published: (2021)

Prescription drug prices : should the federal government regulate them? /
by: Guenther, Gary
Published: (1992)

Drug safety and pricing : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000.
Published: (2000)

Guide to prescription drug costs /
Published: (1980)

Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1990)

Medicare-endorsed prescription drug discount card : their impact on small business : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, first session, Washington, DC, October 25, 2001.
Published: (2002)

Skyrocketing prescription drug prices : hearings before the Special Committee on Aging, United States Senate, One Hundred First Congress, first session, Washington, DC ... July 18, 1989 ... November 16, 1889.
Published: (1990)

Protecting the Safety Net from Waste, Fraud, and Abuse.
Published: (2015)

Prescription drugs : prices available through discount cards and from other sources.
by: Dummit, Laura A.
Published: (2001)

The effects of escalating drug costs on the elderly : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : morning session, Macon, GA, April 22, 1992; afternoon session, Atlanta, GA, April 22, 1992.
Published: (1992)

Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.
Published: (1986)

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.
Published: (2003)